An investigation for investors in Bellerophon Therapeutics Inc (NASDAQ:BLPH) shares over potential securities laws violations by Bellerophon Therapeutics was announced and NASDAQ:BLPH stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 08/10/2015 --An investigation for investors who purchased shares of Bellerophon Therapeutics Inc (NASDAQ:BLPH) over potential violations of securities laws violations by Bellerophon Therapeutics and certain of its directors and officers in connection certain financial statements was announced.

Investors who purchased shares of Bellerophon Therapeutics Inc (NASDAQ:BLPH), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Bellerophon Therapeutics Inc (NASDAQ:BLPH) concerning whether a series of statements by Bellerophon Therapeutics regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On July 27, 2015, Bellerophon Therapeutics Inc announced top-line results from its PRESERVATION I clinical trial for Bioabsorbable Cardiac Matrix (BCM), an investigational, implantable medical device being studied for the prevention of heart failure following an acute myocardial infarction (AMI), commonly known as a heart attack. Bellerophon Therapeutics Inc said that topline results of the 303-patient, randomized, double-blind, placebo-controlled study, enrolled at 61 clinical sites in Australia, Europe, Israel and North America, showed no statistically significant treatment differences between patients treated with BCM and patients treated with placebo for both the primary and the secondary endpoints. Shares of Bellerophon Therapeutics Inc (NASDAQ:BLPH0 dropped on July 27, 2015, to as low as $2.75 per share.

On August 6, 2015, NASDAQ:BLPH shares closed at $3.00 per share.

Those who purchased shares of Bellerophon Therapeutics Inc (NASDAQ:BLPH) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com